DRGV yields 1000000.00% · MRK yields 2.76%● Live data
📍 DRGV pulled ahead of the other in Year 1
Combined, DRGV + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DRGV + MRK for your $10,000?
Dragon Capital Group, Corp., through its subsidiaries, provides software solutions for businesses primarily in the People's Republic of China and the United States. It offers various software applications, including network software, gas pipeline risk assessment system, e-business software development, financial and enterprise information management systems, and computerized automation control applications for commercial and residential buildings, commercial third-generation wireless applications, and mobile business solutions, and multi imaging applications. The company develops commercial 3G wireless applications and mobile business solutions for the human resources, mobile banking, food, beverage, and entertainment industries. In addition, it provides an ERS software system for enterprises to manage accounting, distribution, inventory, and sales; and sells and distributes electronic equipments and devices, and technology solutions to financial institutions, telecommunication companies, hospitals, supermarkets, airports, railway stations, and various government agencies. Additionally, it provides support services in general business consulting, formation of joint ventures, access to capital markets, merger and acquisition transactions consulting, business valuation, and revenue growth strategies. The company was formerly known as Dragon Venture and changed its name to Dragon Capital Group, Corp. in March 2005. Dragon Capital Group, Corp. was incorporated in 1977 and is headquartered in Shanghai, China.
Full DRGV Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.